Radecke S, Schwarz K, Radecke F.
Mol Ther. 2018 Jan 3;26(1):115-131.
Radecke S, Schwarz K, Radecke F.
Mol Ther. 2018 Jan 3;26(1):115-131.
Oligonucleotide Therapeutics Society
3960 W Point Loma Blvd, Suite H
Box 346
San Diego, CA 92110
info@oligotherapeutics.org
© Copyright 2012 – 2024 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing